NASDAQ:TCDAQ

Tricida (TCDAQ) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
$0.0070
$0.0147
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
TCDAQ stock logo

About Tricida Stock (NASDAQ:TCDAQ)

Tricida, Inc. is a pharmaceutical company. It focuses on the development and commercialization of its product, TRC101, a non-absorbed, orally-administered polymer drug designed to treat metabolic acidosis in patients with chronic kidney disease. The company was founded by Gerrit Klaerner and Craig Jon Hawker on May 22, 2013 and is headquartered in South San Francisco, CA.

TCDAQ Stock News Headlines

BAF Viet Nam Agriculture JSC (BAF)
Don’t Miss Out on the AI Gold Rush That’s Just Getting Started
“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.
RattanIndia Power Ltd (RTNP)
Tofas Turk Otomobil Fabrikasi AS (TOASO)
Mag Silver (NYSEMKT: MAG)
Tricida, Inc. (TCDAQ)
See More Headlines
Receive TCDAQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tricida and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/23/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:TCDAQ
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
37,370,000
Optionable
Optionable
Beta
N/A
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Gerrit Klaerner
    President, Chief Executive Officer & Director
  • Geoffrey M. Parker
    Chief Operating & Financial Officer, Executive VP
  • Robert McKague
    Chief Compliance Officer, EVP & General Counsel
  • Annie Yoshiyama
    Chief Accounting Officer & Senior VP-Finance
  • Jacqueline Cossmon
    Senior VP-Investor Relations & Communications

This page (NASDAQ:TCDAQ) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners